Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SK HEALTH APS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.4% 6.3% 6.0% 3.5% 2.9% 4.0% 13.0% 13.0%   Credit score (0-100)   43 39 39 51 58 49 18 18   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   355 215 274 785 996 1,013 0.0 0.0   EBITDA   355 215 274 336 531 493 0.0 0.0   EBIT   355 215 274 330 510 478 0.0 0.0   Pre-tax profit (PTP)   355.1 213.7 272.1 354.6 432.2 296.6 0.0 0.0   Net earnings   273.4 167.4 210.5 273.9 335.5 187.8 0.0 0.0   Pre-tax profit without non-rec. items   355 214 272 355 432 297 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   849 951 1,097 1,306 1,576 1,699 1,103 1,103   Interest-bearing liabilities   10.1 10.7 17.4 6.4 8.3 5.8 0.0 0.0   Balance sheet total (assets)   998 1,057 1,292 1,490 1,656 1,912 1,103 1,103   Net Debt   -683 -465 -858 -1,228 -1,142 -1,067 -1,103 -1,103     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   355 215 274 785 996 1,013 0.0 0.0   Gross profit growth   409.3% -39.6% 27.8% 186.3% 26.9% 1.7% -100.0% 0.0%   Employees   0 0 0 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   998 1,057 1,292 1,490 1,656 1,912 1,103 1,103   Balance sheet change%   23.1% 6.0% 22.2% 15.3% 11.2% 15.5% -42.3% 0.0%   Added value   355.1 214.6 274.3 335.9 516.0 493.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 -6 -20 -15 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 42.0% 51.2% 47.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.3% 20.9% 23.4% 25.9% 33.5% 27.5% 0.0% 0.0%   ROI %   49.1% 23.6% 26.4% 29.7% 36.4% 29.9% 0.0% 0.0%   ROE %   38.4% 18.6% 20.6% 22.8% 23.3% 11.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   85.3% 90.0% 84.9% 87.7% 95.2% 88.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -192.4% -216.5% -312.8% -365.5% -215.1% -216.3% 0.0% 0.0%   Gearing %   1.2% 1.1% 1.6% 0.5% 0.5% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 8.8% 15.8% 51.2% 1,296.4% 2,758.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   5.7 6.3 5.2 7.5 19.6 7.0 0.0 0.0   Current Ratio   6.4 9.6 6.4 7.8 20.1 8.9 0.0 0.0   Cash and cash equivalent   693.2 475.4 875.6 1,234.1 1,149.9 1,072.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   803.5 905.7 1,051.0 1,060.1 1,226.5 1,552.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 336 516 493 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 336 531 493 0 0   EBIT / employee   0 0 0 330 510 478 0 0   Net earnings / employee   0 0 0 274 336 188 0 0